Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
74.34
-3.86 (-4.94%)
At close: Jul 31, 2026, 4:00 PM EDT
74.75
+0.41 (0.55%)
After-hours: Jul 31, 2026, 7:34 PM EDT
KNSA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Net Income | 25.43 | 22.59 | 14.2 | 18.44 | 17.83 | 8.54 | -8.89 | -12.69 | -3.91 | -17.7 | 25.24 | -13.86 | 14.97 | -12.27 | 4.46 | 224.09 | -19.98 | -25.21 | -36.33 | -30.54 |
Depreciation & Amortization | 0.47 | 0.47 | 0.47 | 0.38 | 0.36 | 0.35 | 0.4 | 0.4 | 0.43 | 0.47 | 0.54 | 0.6 | 0.6 | 0.6 | 0.6 | 0.49 | 0.65 | 0.66 | 0.67 | 0.66 |
Stock-Based Compensation | 11.64 | 10.06 | 10.24 | 10.14 | 8.88 | 7.75 | 8.3 | 7.83 | 7.36 | 7.21 | 7.77 | 6.79 | 6.47 | 6.12 | 6.37 | 6.04 | 6.68 | 6.03 | 6.13 | 6.2 |
Other Adjustments | 3.79 | 6.77 | 3.12 | 5.73 | 2.69 | 4.09 | -1.58 | -3.37 | 11.19 | 5.44 | 8.52 | 12.44 | -19.83 | 1.03 | 0.94 | -185.2 | 0.86 | 0.9 | 0.9 | 0.72 |
Change in Receivables | -0.27 | -7.63 | 7.31 | -19.83 | 8.16 | 1.66 | -16.84 | -4.44 | -4.46 | 5.27 | -18.23 | 21.61 | -17.23 | 5.24 | -1.5 | -3.35 | 21.63 | -25.46 | -0.69 | -0.67 |
Changes in Inventories | 2.21 | -18.25 | -13.5 | 6.79 | -26.11 | 4.3 | 2.32 | 6.18 | -7.58 | 3.84 | -5.54 | -1.63 | -0.53 | -1.83 | -6.98 | 5.3 | -6.69 | -9.55 | 1.93 | 0.78 |
Changes in Accounts Payable | -12 | 22.27 | -4.12 | -2.73 | 6.93 | 0.06 | -6.28 | 0.91 | 1.73 | -2.66 | 7.23 | 0.36 | -0.74 | -6.51 | 6.43 | -1.05 | -0.86 | 1.52 | 0.25 | -2.54 |
Changes in Accrued Expenses | 25.79 | -5.05 | 19.63 | 8.37 | 13.1 | -3.6 | 10.99 | 10.8 | 18.66 | 3.29 | 5.29 | 7.61 | 14.69 | -10.65 | -5.79 | 1.97 | -5.97 | 4.09 | 10.04 | -2.46 |
Changes in Unearned Revenue | - | - | 19.55 | - | - | - | 20 | -0 | -0.16 | -0.29 | -2.18 | -2.24 | -1.98 | 6.66 | -14.29 | 14.29 | 0 | 12 | -0.08 | 0.08 |
Changes in Other Operating Activities | -9.87 | 18.98 | -34.53 | 6.39 | -3.74 | -0.82 | 10.35 | -7.84 | -18.1 | -0.87 | 9.44 | -14.7 | -0.18 | 7.35 | -3.82 | -0.53 | -4.13 | -1.82 | -1.71 | -0.72 |
Operating Cash Flow | 47.2 | 50.2 | 53.89 | 33.68 | 28.09 | 22.32 | 18.77 | -2.24 | 5.17 | 3.99 | 4.33 | 16.99 | -3.74 | -4.27 | -11.58 | 62.05 | -7.82 | -36.85 | -18.88 | -28.51 |
Operating Cash Flow Growth (YoY) | 68.01% | 124.87% | 187.13% | - | 443.54% | 459.92% | 333.99% | - | - | - | - | -72.63% | - | - | - | - | - | - | - | - |
Capital Expenditures | -0.66 | -0.16 | -0.63 | -0.67 | -0.17 | -0.1 | -0.19 | 0 | 0 | -0.08 | -0.06 | -0.02 | -0.03 | -0.02 | 0.03 | -0.02 | -0.12 | - | -0.25 | -0.05 |
Sale of Property, Plant & Equipment | - | - | - | - | - | - | 0 | 0 | 0.03 | - | - | - | - | - | 0.01 | -0.01 | - | - | - | - |
Purchases of Investments | -109.62 | -177.41 | -110.96 | -146.16 | -34.32 | -95.47 | -21.99 | -54.48 | -89.26 | -36.28 | -60.82 | -53.09 | -38.13 | -52.9 | -62.8 | -17.33 | -25.51 | -30.22 | -59.79 | 0 |
Proceeds from Sale of Investments | 36.7 | 145.66 | 40.78 | 84.08 | 30.61 | 44.03 | 87.48 | 48.13 | 42.44 | 61.88 | 45.98 | 40.83 | 73.7 | 15 | 20.1 | 36.4 | 63.8 | 7.5 | 10 | 47.9 |
Investing Cash Flow | -73.58 | -31.92 | -70.81 | -62.76 | -3.88 | -51.54 | 65.29 | -6.35 | -46.8 | 25.52 | -14.89 | -12.28 | 35.53 | -37.92 | -42.66 | 19.04 | 38.27 | -22.72 | -50.04 | 47.85 |
Issuance of Common Stock | 17.58 | 6.39 | 8.58 | 16.25 | 12.75 | 3.18 | 2.72 | 9.4 | 1.14 | 3.99 | 0.96 | 1.66 | 0.58 | 0.51 | 1.29 | 0.57 | 0.57 | 0.99 | 1.21 | 2.68 |
Repurchase of Common Stock | -5.47 | -0.32 | -0.92 | -4.35 | -2.05 | -0.41 | -0.58 | -2.71 | -1.31 | -0.38 | -0.26 | -1.11 | -0.42 | -0.42 | -0.1 | -0.21 | -0.02 | -0.57 | - | - |
Net Common Stock Issued (Repurchased) | 12.11 | 6.07 | 7.66 | 11.9 | 10.7 | 2.77 | 2.14 | 6.69 | -0.18 | 3.61 | 0.7 | 0.55 | 0.16 | 0.09 | 1.19 | 0.36 | 0.54 | 0.42 | 1.21 | 2.68 |
Financing Cash Flow | 12.11 | 6.07 | 7.66 | 11.9 | 10.7 | 2.77 | 2.14 | 6.69 | -0.18 | 3.61 | 0.7 | 0.55 | 0.16 | 0.09 | 1.19 | 0.36 | 0.54 | 0.42 | 1.21 | 2.68 |
Net Cash Flow | -14.28 | 24.36 | -9.26 | -17.18 | 34.91 | -26.45 | 86.21 | -1.9 | -41.81 | 33.12 | -9.87 | 5.26 | 31.95 | -42.1 | -53.05 | 81.45 | 30.98 | -59.15 | -67.71 | 22.02 |
Free Cash Flow | 46.53 | 50.04 | 53.26 | 33.01 | 27.93 | 22.23 | 18.58 | -2.24 | 5.17 | 3.9 | 4.27 | 16.97 | -3.78 | -4.29 | -11.54 | 62.03 | -7.94 | -36.85 | -19.14 | -28.56 |
Free Cash Flow Growth (YoY) | 66.63% | 125.14% | 186.70% | - | 440.34% | 469.43% | 335.16% | - | - | - | - | -72.64% | - | - | - | - | - | - | - | - |
FCF Margin | 19.10% | 23.35% | 26.35% | 18.25% | 17.81% | 16.13% | 15.16% | -1.99% | 4.76% | 4.89% | 5.12% | 25.31% | -5.28% | -8.88% | -18.65% | 62.57% | -29.43% | -114.47% | -102.08% | -236.13% |
Free Cash Flow Per Share | 0.56 | 0.61 | 0.65 | 0.41 | 0.36 | 0.29 | 0.26 | -0.03 | 0.07 | 0.06 | 0.06 | 0.24 | -0.05 | -0.06 | -0.16 | 0.88 | -0.11 | -0.53 | -0.28 | -0.42 |
Levered Free Cash Flow | 31.38 | 40.85 | 1.06 | 36.96 | 8.2 | 8.73 | 28.69 | -2.25 | -8.93 | -14.02 | 39.97 | -23.86 | 26.8 | -16.67 | -19.36 | 244.54 | -37.1 | -18.32 | -25.48 | -34.8 |
Unlevered Free Cash Flow | 28.15 | 38.49 | 6.63 | 34.83 | 6.09 | 7.47 | 18.28 | -6.58 | -4.83 | -16.83 | 15.56 | -27.82 | 49.94 | -19.07 | -19.88 | 243 | -37.21 | -18.36 | -25.55 | -34.81 |